Schwartz M - Search Results

1

Development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (SEARCHER): A multi-institutional observational study.

Chen ZX, Schwartz M, Gu LH, Liang L, Wang P, Cescon M, Li JD, Liang YJ, Pu JL, Zhou YH, Wang H, Gu WM, Chen TH, Chen ZY, Wang MD, Li C, Zhang CW, Pawlik TM, Lau WY, Shen F, Liu FB, Yang T. Chen ZX, et al. Among authors: schwartz m. Int J Surg. 2022 Oct;106:106842. doi: 10.1016/j.ijsu.2022.106842. Epub 2022 Aug 24. Int J Surg. 2022. PMID: 36030039 Free article.

2

Resection of hepatocellular carcinoma without cirrhosis.

Shrager B, Jibara G, Schwartz M, Roayaie S. Shrager B, et al. Among authors: schwartz m. Ann Surg. 2012 Jun;255(6):1135-43. doi: 10.1097/SLA.0b013e31823e70a3. Ann Surg. 2012. PMID: 22258064

3

Transplantation for hepatocellular carcinoma: more haste, less speed?

Yang T, Lau WY, Huang B, Schwartz M, Shen F. Yang T, et al. Among authors: schwartz m. Hepatology. 2015 Oct;62(4):1327-8. doi: 10.1002/hep.27820. Epub 2015 May 9. Hepatology. 2015. PMID: 25820796 No abstract available.

4

Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma.

Yang T, Zhang H, Shen YN, Wu MC, Shen F, Schwartz M. Yang T, et al. Among authors: schwartz m. Am J Gastroenterol. 2015 Apr;110(4):595. doi: 10.1038/ajg.2015.33. Am J Gastroenterol. 2015. PMID: 25853196 No abstract available.

5

Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma.

Shen YN, Zhang H, Lu JH, Schwartz ME, Yang T. Shen YN, et al. J Gastrointest Surg. 2015 Jun;19(6):1192-3. doi: 10.1007/s11605-015-2822-3. Epub 2015 Apr 21. J Gastrointest Surg. 2015. PMID: 25895978 No abstract available.

6

Reporting and methodological qualities of published surgical meta-analyses.

Zhang H, Han J, Zhu YB, Lau WY, Schwartz ME, Xie GQ, Dai SY, Shen YN, Wu MC, Shen F, Yang T. Zhang H, et al. J Clin Epidemiol. 2016 Feb;70:4-16. doi: 10.1016/j.jclinepi.2015.06.009. Epub 2015 Jun 24. J Clin Epidemiol. 2016. PMID: 26117439

7

Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.

Yang T, Lu JH, Lau WY, Zhang TY, Zhang H, Shen YN, Alshebeeb K, Wu MC, Schwartz M, Shen F. Yang T, et al. Among authors: schwartz m. J Hepatol. 2016 Mar;64(3):583-93. doi: 10.1016/j.jhep.2015.10.012. Epub 2015 Oct 24. J Hepatol. 2016. PMID: 26596543

8

Reply to "Association of blood transfusion during resection for hepatocellular carcinoma with postoperative recurrence and overall survival: A cautionary comment".

Yang T, Shen F, Schwartz M. Yang T, et al. Among authors: schwartz m. J Hepatol. 2016 Jul;65(1):229-230. doi: 10.1016/j.jhep.2016.04.002. Epub 2016 Apr 7. J Hepatol. 2016. PMID: 27063565 No abstract available.

9

Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West.

Yang T, Tabrizian P, Zhang H, Lau WY, Han J, Li ZL, Wang Z, Wu MC, Florman S, Schwartz ME, Shen F. Yang T, et al. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1972-1974. doi: 10.1016/j.cgh.2017.06.025. Epub 2017 Jun 17. Clin Gastroenterol Hepatol. 2017. PMID: 28634137 No abstract available.

10

Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study.

Zhang H, Han J, Xing H, Li ZL, Schwartz ME, Zhou YH, Chen TH, Wang H, Gu WM, Lau WY, Wu H, Wu MC, Shen F, Yang T. Zhang H, et al. Surgery. 2019 Mar;165(3):516-524. doi: 10.1016/j.surg.2018.08.031. Epub 2018 Oct 15. Surgery. 2019. PMID: 30337048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,285 results

Search Page

Filters